140 related articles for article (PubMed ID: 37701974)
1. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma.
Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY
Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma.
Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A
Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666
[TBL] [Abstract][Full Text] [Related]
3. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
[TBL] [Abstract][Full Text] [Related]
5. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder.
Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H
Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881
[TBL] [Abstract][Full Text] [Related]
6. Survival associated miRNA signature in patients with head and neck carcinomas.
Yerukala Sathipati S; Ho SY
Heliyon; 2023 Jun; 9(6):e17218. PubMed ID: 37360084
[TBL] [Abstract][Full Text] [Related]
7. [Identification of onco-miRNAs in hepatocellular carcinoma and analysis of their regulatory network].
Ye J; Xu W; Chen T
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):45-54. PubMed ID: 35249869
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
[TBL] [Abstract][Full Text] [Related]
9. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
10. A novel prognostic model for hepatocellular carcinoma based on 5 microRNAs related to vascular invasion.
Chen W; Wang H; Li T; Liu T; Yang W; Jin A; Ding L; Zhang C; Pan B; Guo W; Wang B
BMC Med Genomics; 2022 Feb; 15(1):34. PubMed ID: 35197055
[TBL] [Abstract][Full Text] [Related]
11. Identification and analysis of circRNA-miRNA-mRNA regulatory network in hepatocellular carcinoma.
Zhou D; Dong L; Yang L; Ma Q; Liu F; Li Y; Xiong S
IET Syst Biol; 2020 Dec; 14(6):391-398. PubMed ID: 33399102
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
[No Abstract] [Full Text] [Related]
13. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
14. Identification of Four Oxidative Stress-Responsive MicroRNAs, miR-34a-5p, miR-1915-3p, miR-638, and miR-150-3p, in Hepatocellular Carcinoma.
Wan Y; Cui R; Gu J; Zhang X; Xiang X; Liu C; Qu K; Lin T
Oxid Med Cell Longev; 2017; 2017():5189138. PubMed ID: 28811864
[TBL] [Abstract][Full Text] [Related]
15. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma.
Zhang Q; Luo Y; Zhang S; Huang Q; Liu G
Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747
[TBL] [Abstract][Full Text] [Related]
16. Elucidating hepatocellular carcinoma progression: a novel prognostic miRNA-mRNA network and signature analysis.
Wang F; Kang X; Li Y; Lu J; Liu X; Yan H
Sci Rep; 2024 Feb; 14(1):5042. PubMed ID: 38424172
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
18. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
Lu M; Kong X; Wang H; Huang G; Ye C; He Z
Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
[TBL] [Abstract][Full Text] [Related]
19. A P53-related microRNA model for predicting the prognosis of hepatocellular carcinoma patients.
Fang SS; Guo JC; Zhang JH; Liu JN; Hong S; Yu B; Gao Y; Hu SP; Liu HZ; Sun L; Zhao Y
J Cell Physiol; 2020 Apr; 235(4):3569-3578. PubMed ID: 31556110
[TBL] [Abstract][Full Text] [Related]
20. Identification of the miRNA signature associated with survival in patients with ovarian cancer.
Sathipati SY; Ho SY
Aging (Albany NY); 2021 Apr; 13(9):12660-12690. PubMed ID: 33910165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]